Increased risk of mycobacterial infections associated with anti-rheumatic medications.
Identifieur interne : 000E83 ( Main/Exploration ); précédent : 000E82; suivant : 000E84Increased risk of mycobacterial infections associated with anti-rheumatic medications.
Auteurs : Sarah K. Brode [Canada] ; Frances B. Jamieson [Canada] ; Ryan Ng [Canada] ; Michael A. Campitelli [Canada] ; Jeffrey C. Kwong [Canada] ; J Michael Paterson [Canada] ; Ping Li [Canada] ; Alex Marchand-Austin [Canada] ; Claire Bombardier [Canada] ; Theodore K. Marras [Canada]Source :
- Thorax [ 1468-3296 ] ; 2015.
Descripteurs français
- KwdFr :
- Antirhumatismaux (effets indésirables), Bases de données factuelles, Facteur de nécrose tumorale alpha (antagonistes et inhibiteurs), Femelle, Humains, Immunosuppresseurs (usage thérapeutique), Infections opportunistes (), Infections opportunistes (épidémiologie), Infections à mycobactéries non tuberculeuses (), Infections à mycobactéries non tuberculeuses (épidémiologie), Mâle, Ontario (épidémiologie), Polyarthrite rhumatoïde (), Polyarthrite rhumatoïde (traitement médicamenteux), Polyarthrite rhumatoïde (épidémiologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Tuberculose (), Tuberculose (épidémiologie), Utilisation médicament (), Études cas-témoins, Évaluation des risques ().
- MESH :
- antagonistes et inhibiteurs : Facteur de nécrose tumorale alpha.
- effets indésirables : Antirhumatismaux.
- traitement médicamenteux : Polyarthrite rhumatoïde.
- usage thérapeutique : Immunosuppresseurs.
- épidémiologie : Infections opportunistes, Infections à mycobactéries non tuberculeuses, Ontario, Polyarthrite rhumatoïde, Tuberculose.
- Bases de données factuelles, Femelle, Humains, Infections opportunistes, Infections à mycobactéries non tuberculeuses, Mâle, Polyarthrite rhumatoïde, Sujet âgé, Sujet âgé de 80 ans ou plus, Tuberculose, Utilisation médicament, Études cas-témoins, Évaluation des risques.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Antirheumatic Agents (adverse effects), Arthritis, Rheumatoid (complications), Arthritis, Rheumatoid (drug therapy), Arthritis, Rheumatoid (epidemiology), Case-Control Studies, Databases, Factual, Drug Utilization (statistics & numerical data), Female, Humans, Immunosuppressive Agents (therapeutic use), Male, Mycobacterium Infections, Nontuberculous (chemically induced), Mycobacterium Infections, Nontuberculous (complications), Mycobacterium Infections, Nontuberculous (epidemiology), Ontario (epidemiology), Opportunistic Infections (chemically induced), Opportunistic Infections (complications), Opportunistic Infections (epidemiology), Risk Assessment (methods), Tuberculosis (chemically induced), Tuberculosis (complications), Tuberculosis (epidemiology), Tumor Necrosis Factor-alpha (antagonists & inhibitors).
- MESH :
- chemical , adverse effects : Antirheumatic Agents.
- chemical , antagonists & inhibitors : Tumor Necrosis Factor-alpha.
- geographic , epidemiology : Ontario.
- chemically induced : Mycobacterium Infections, Nontuberculous, Opportunistic Infections, Tuberculosis.
- complications : Arthritis, Rheumatoid, Mycobacterium Infections, Nontuberculous, Opportunistic Infections, Tuberculosis.
- drug therapy : Arthritis, Rheumatoid.
- epidemiology : Arthritis, Rheumatoid, Mycobacterium Infections, Nontuberculous, Opportunistic Infections, Tuberculosis.
- methods : Risk Assessment.
- statistics & numerical data : Drug Utilization.
- chemical , therapeutic use : Immunosuppressive Agents.
- Aged, Aged, 80 and over, Case-Control Studies, Databases, Factual, Female, Humans, Male.
Abstract
Anti-tumour necrosis factor (TNF) agents and other anti-rheumatic medications increase the risk of TB in rheumatoid arthritis (RA). Whether they increase the risk of infections with nontuberculous mycobacteria (NTM) is uncertain.
DOI: 10.1136/thoraxjnl-2014-206470
PubMed: 25911222
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000257
- to stream PubMed, to step Curation: 000257
- to stream PubMed, to step Checkpoint: 000235
- to stream Ncbi, to step Merge: 000288
- to stream Ncbi, to step Curation: 000288
- to stream Ncbi, to step Checkpoint: 000288
- to stream Main, to step Merge: 000E84
- to stream Main, to step Curation: 000E83
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increased risk of mycobacterial infections associated with anti-rheumatic medications.</title><author><name sortKey="Brode, Sarah K" sort="Brode, Sarah K" uniqKey="Brode S" first="Sarah K" last="Brode">Sarah K. Brode</name><affiliation wicri:level="1"><nlm:affiliation>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada West Park Healthcare Centre, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada West Park Healthcare Centre, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Jamieson, Frances B" sort="Jamieson, Frances B" uniqKey="Jamieson F" first="Frances B" last="Jamieson">Frances B. Jamieson</name><affiliation wicri:level="4"><nlm:affiliation>Public Health Ontario, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Public Health Ontario, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Ng, Ryan" sort="Ng, Ryan" uniqKey="Ng R" first="Ryan" last="Ng">Ryan Ng</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name><affiliation wicri:level="4"><nlm:affiliation>Public Health Ontario, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada Toronto Western Family Health Team, University Health Network, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Public Health Ontario, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada Toronto Western Family Health Team, University Health Network, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Paterson, J Michael" sort="Paterson, J Michael" uniqKey="Paterson J" first="J Michael" last="Paterson">J Michael Paterson</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Family Medicine, McMaster University, Hamilton, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Marchand Austin, Alex" sort="Marchand Austin, Alex" uniqKey="Marchand Austin A" first="Alex" last="Marchand-Austin">Alex Marchand-Austin</name><affiliation wicri:level="1"><nlm:affiliation>Public Health Ontario, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Public Health Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Bombardier, Claire" sort="Bombardier, Claire" uniqKey="Bombardier C" first="Claire" last="Bombardier">Claire Bombardier</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Toronto General Hospital Research Institute, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Toronto General Hospital Research Institute, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Marras, Theodore K" sort="Marras, Theodore K" uniqKey="Marras T" first="Theodore K" last="Marras">Theodore K. Marras</name><affiliation wicri:level="1"><nlm:affiliation>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25911222</idno><idno type="pmid">25911222</idno><idno type="doi">10.1136/thoraxjnl-2014-206470</idno><idno type="wicri:Area/PubMed/Corpus">000257</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000257</idno><idno type="wicri:Area/PubMed/Curation">000257</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000257</idno><idno type="wicri:Area/PubMed/Checkpoint">000235</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000235</idno><idno type="wicri:Area/Ncbi/Merge">000288</idno><idno type="wicri:Area/Ncbi/Curation">000288</idno><idno type="wicri:Area/Ncbi/Checkpoint">000288</idno><idno type="wicri:Area/Main/Merge">000E84</idno><idno type="wicri:Area/Main/Curation">000E83</idno><idno type="wicri:Area/Main/Exploration">000E83</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Increased risk of mycobacterial infections associated with anti-rheumatic medications.</title><author><name sortKey="Brode, Sarah K" sort="Brode, Sarah K" uniqKey="Brode S" first="Sarah K" last="Brode">Sarah K. Brode</name><affiliation wicri:level="1"><nlm:affiliation>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada West Park Healthcare Centre, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada West Park Healthcare Centre, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Jamieson, Frances B" sort="Jamieson, Frances B" uniqKey="Jamieson F" first="Frances B" last="Jamieson">Frances B. Jamieson</name><affiliation wicri:level="4"><nlm:affiliation>Public Health Ontario, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Public Health Ontario, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Ng, Ryan" sort="Ng, Ryan" uniqKey="Ng R" first="Ryan" last="Ng">Ryan Ng</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name><affiliation wicri:level="4"><nlm:affiliation>Public Health Ontario, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada Toronto Western Family Health Team, University Health Network, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Public Health Ontario, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada Toronto Western Family Health Team, University Health Network, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Paterson, J Michael" sort="Paterson, J Michael" uniqKey="Paterson J" first="J Michael" last="Paterson">J Michael Paterson</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Department of Family Medicine, McMaster University, Hamilton, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute for Clinical Evaluative Sciences, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Marchand Austin, Alex" sort="Marchand Austin, Alex" uniqKey="Marchand Austin A" first="Alex" last="Marchand-Austin">Alex Marchand-Austin</name><affiliation wicri:level="1"><nlm:affiliation>Public Health Ontario, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Public Health Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Bombardier, Claire" sort="Bombardier, Claire" uniqKey="Bombardier C" first="Claire" last="Bombardier">Claire Bombardier</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Toronto General Hospital Research Institute, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Toronto General Hospital Research Institute, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Marras, Theodore K" sort="Marras, Theodore K" uniqKey="Marras T" first="Theodore K" last="Marras">Theodore K. Marras</name><affiliation wicri:level="1"><nlm:affiliation>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Joint Division of Respirology, Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada Department of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><series><title level="j">Thorax</title><idno type="eISSN">1468-3296</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Antirheumatic Agents (adverse effects)</term><term>Arthritis, Rheumatoid (complications)</term><term>Arthritis, Rheumatoid (drug therapy)</term><term>Arthritis, Rheumatoid (epidemiology)</term><term>Case-Control Studies</term><term>Databases, Factual</term><term>Drug Utilization (statistics & numerical data)</term><term>Female</term><term>Humans</term><term>Immunosuppressive Agents (therapeutic use)</term><term>Male</term><term>Mycobacterium Infections, Nontuberculous (chemically induced)</term><term>Mycobacterium Infections, Nontuberculous (complications)</term><term>Mycobacterium Infections, Nontuberculous (epidemiology)</term><term>Ontario (epidemiology)</term><term>Opportunistic Infections (chemically induced)</term><term>Opportunistic Infections (complications)</term><term>Opportunistic Infections (epidemiology)</term><term>Risk Assessment (methods)</term><term>Tuberculosis (chemically induced)</term><term>Tuberculosis (complications)</term><term>Tuberculosis (epidemiology)</term><term>Tumor Necrosis Factor-alpha (antagonists & inhibitors)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antirhumatismaux (effets indésirables)</term><term>Bases de données factuelles</term><term>Facteur de nécrose tumorale alpha (antagonistes et inhibiteurs)</term><term>Femelle</term><term>Humains</term><term>Immunosuppresseurs (usage thérapeutique)</term><term>Infections opportunistes ()</term><term>Infections opportunistes (épidémiologie)</term><term>Infections à mycobactéries non tuberculeuses ()</term><term>Infections à mycobactéries non tuberculeuses (épidémiologie)</term><term>Mâle</term><term>Ontario (épidémiologie)</term><term>Polyarthrite rhumatoïde ()</term><term>Polyarthrite rhumatoïde (traitement médicamenteux)</term><term>Polyarthrite rhumatoïde (épidémiologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tuberculose ()</term><term>Tuberculose (épidémiologie)</term><term>Utilisation médicament ()</term><term>Études cas-témoins</term><term>Évaluation des risques ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antirheumatic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Tumor Necrosis Factor-alpha</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Facteur de nécrose tumorale alpha</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Mycobacterium Infections, Nontuberculous</term><term>Opportunistic Infections</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Arthritis, Rheumatoid</term><term>Mycobacterium Infections, Nontuberculous</term><term>Opportunistic Infections</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antirhumatismaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Arthritis, Rheumatoid</term><term>Mycobacterium Infections, Nontuberculous</term><term>Opportunistic Infections</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Risk Assessment</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Drug Utilization</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Immunosuppressive Agents</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Immunosuppresseurs</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections opportunistes</term><term>Infections à mycobactéries non tuberculeuses</term><term>Ontario</term><term>Polyarthrite rhumatoïde</term><term>Tuberculose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Case-Control Studies</term><term>Databases, Factual</term><term>Female</term><term>Humans</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Bases de données factuelles</term><term>Femelle</term><term>Humains</term><term>Infections opportunistes</term><term>Infections à mycobactéries non tuberculeuses</term><term>Mâle</term><term>Polyarthrite rhumatoïde</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tuberculose</term><term>Utilisation médicament</term><term>Études cas-témoins</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Anti-tumour necrosis factor (TNF) agents and other anti-rheumatic medications increase the risk of TB in rheumatoid arthritis (RA). Whether they increase the risk of infections with nontuberculous mycobacteria (NTM) is uncertain.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Brode, Sarah K" sort="Brode, Sarah K" uniqKey="Brode S" first="Sarah K" last="Brode">Sarah K. Brode</name></noRegion><name sortKey="Bombardier, Claire" sort="Bombardier, Claire" uniqKey="Bombardier C" first="Claire" last="Bombardier">Claire Bombardier</name><name sortKey="Campitelli, Michael A" sort="Campitelli, Michael A" uniqKey="Campitelli M" first="Michael A" last="Campitelli">Michael A. Campitelli</name><name sortKey="Jamieson, Frances B" sort="Jamieson, Frances B" uniqKey="Jamieson F" first="Frances B" last="Jamieson">Frances B. Jamieson</name><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name><name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name><name sortKey="Marchand Austin, Alex" sort="Marchand Austin, Alex" uniqKey="Marchand Austin A" first="Alex" last="Marchand-Austin">Alex Marchand-Austin</name><name sortKey="Marras, Theodore K" sort="Marras, Theodore K" uniqKey="Marras T" first="Theodore K" last="Marras">Theodore K. Marras</name><name sortKey="Ng, Ryan" sort="Ng, Ryan" uniqKey="Ng R" first="Ryan" last="Ng">Ryan Ng</name><name sortKey="Paterson, J Michael" sort="Paterson, J Michael" uniqKey="Paterson J" first="J Michael" last="Paterson">J Michael Paterson</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E83 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E83 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25911222
|texte= Increased risk of mycobacterial infections associated with anti-rheumatic medications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25911222" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |